Cigna Corp., Sarepta Therapeutics sales and marketing update

Cigna will cover Exondys 51 eteplirsen from Sarepta to treat Duchenne muscular dystrophy (DMD) “in patients who have a confirmed mutation of a specific section of the DMD gene.” FDA granted accelerat...